464 related articles for article (PubMed ID: 14600187)
21. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial.
Morelli A; Ricci Z; Bellomo R; Ronco C; Rocco M; Conti G; De Gaetano A; Picchini U; Orecchioni A; Portieri M; Coluzzi F; Porzi P; Serio P; Bruno A; Pietropaoli P
Crit Care Med; 2005 Nov; 33(11):2451-6. PubMed ID: 16276165
[TBL] [Abstract][Full Text] [Related]
22. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.
Brar SS; Shen AY; Jorgensen MB; Kotlewski A; Aharonian VJ; Desai N; Ree M; Shah AI; Burchette RJ
JAMA; 2008 Sep; 300(9):1038-46. PubMed ID: 18768415
[TBL] [Abstract][Full Text] [Related]
23. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
[TBL] [Abstract][Full Text] [Related]
24. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
[TBL] [Abstract][Full Text] [Related]
25. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients.
Madyoon H; Croushore L; Weaver D; Mathur V
Catheter Cardiovasc Interv; 2001 Jul; 53(3):341-5. PubMed ID: 11458411
[TBL] [Abstract][Full Text] [Related]
26. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
[TBL] [Abstract][Full Text] [Related]
27. Fenoldopam for the prevention of contrast-induced nephropathy (CIN)-do we need more trials? A meta-analysis.
Naeem M; McEnteggart GE; Murphy TP; Prince E; Ahn S; Soares G
Clin Imaging; 2015; 39(5):759-64. PubMed ID: 25709111
[TBL] [Abstract][Full Text] [Related]
28. Use of fenoldopam to control renal dysfunction early after liver transplantation.
Biancofiore G; Della Rocca G; Bindi L; Romanelli A; Esposito M; Meacci L; Urbani L; Filipponi F; Mosca F
Liver Transpl; 2004 Aug; 10(8):986-92. PubMed ID: 15390323
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Madyoon H
Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Webb JG; Pate GE; Humphries KH; Buller CE; Shalansky S; Al Shamari A; Sutander A; Williams T; Fox RS; Levin A
Am Heart J; 2004 Sep; 148(3):422-9. PubMed ID: 15389228
[TBL] [Abstract][Full Text] [Related]
32. Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial).
Stone GW; Vora K; Schindler J; Diaz C; Mann T; Dangas G; Best P; Cutlip DE;
Am J Cardiol; 2011 Sep; 108(5):741-6. PubMed ID: 21676368
[TBL] [Abstract][Full Text] [Related]
33. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.
Miner SE; Dzavik V; Nguyen-Ho P; Richardson R; Mitchell J; Atchison D; Seidelin P; Daly P; Ross J; McLaughlin PR; Ing D; Lewycky P; Barolet A; Schwartz L
Am Heart J; 2004 Oct; 148(4):690-5. PubMed ID: 15459602
[TBL] [Abstract][Full Text] [Related]
34. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting.
Halpenny M; Lakshmi S; O'Donnell A; O'Callaghan-Enright S; Shorten GD
Anaesthesia; 2001 Oct; 56(10):953-60. PubMed ID: 11576097
[TBL] [Abstract][Full Text] [Related]
35. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
Merten GJ; Burgess WP; Gray LV; Holleman JH; Roush TS; Kowalchuk GJ; Bersin RM; Van Moore A; Simonton CA; Rittase RA; Norton HJ; Kennedy TP
JAMA; 2004 May; 291(19):2328-34. PubMed ID: 15150204
[TBL] [Abstract][Full Text] [Related]
36. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
37. Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
Walker PD; Brokering KL; Theobald JC
Pharmacotherapy; 2003 Dec; 23(12):1617-26. PubMed ID: 14695041
[TBL] [Abstract][Full Text] [Related]
38. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
[TBL] [Abstract][Full Text] [Related]
39. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
40. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
